Recent advances in cancer diagnostics include the development of liquid biopsies, which detect cancer cells or DNA fragments in blood samples. This non-invasive technique offers the potential for early detection and monitoring of treatment response. Additionally, Artificial Intelligence (AI) is being used to analyze imaging data and genetic information, improving diagnostic accuracy and personalized treatment plans.
